Latvia Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Latvia Pharmaceuticals and Healthcare Report

Latvia Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Latvia Pharmaceuticals and Healthcare Report
Published Aug 20, 2016
80 pages — Published Aug 20, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Inevitable government cost-reduction measures, which may include stricter pricing policies, to slow market growth in the longer run. Much-needed investment in hospitals and growing wage demands to claim most available additional spending, thus hampering funding increases for pharmaceuticals. ...Inevitable government cost-reduction measures, which may include stricter pricing policies, to slow market growth in the longer run. Much-needed investment in hospitals and growing wage demands to claim most available additional spending, thus hampering funding increases for pharmaceuticals. Policy to remain focused on restraining pharmaceutical price growth, limiting the attractiveness of the market for importers. ...Bribery and corruption present in healthcare services. Eurozone risks relating to Greek bailout could impact on pharmaceutical market imports and exports via exchange rate fluctuations.

...In BMI s Q--- Pharmaceutical Risk/Reward Index (RRI) Latvia is ranked --th out of the -- markets in the Central and Eastern European (CEE) matrix with an improved score of --.- compared with the previous quarter (--.-). Latvia s score remains below the regional average of --.-, indicating the country s challenging business environment, particularly in terms of potential industry rewards and the potential impact of the eurozone crisis. ...In BMI s Q--- Pharmaceutical Risk/Reward Index (RRI) Latvia is ranked --th out of the -- markets in the Central and Eastern European (CEE) matrix with an improved score of --.- compared with the previous quarter (--.-). Latvia s score remains below the regional average of --.-, indicating the country s challenging business environment, particularly in terms of potential industry rewards and the potential impact of the eurozone crisis. Consequently, direct multinational operations are limited and domestic companies, such as Grindeks, have looked abroad for growth opportunities. ...Latvia s score remains below the regional average of --.-, indicating the country s challenging business environment, particularly in terms of potential industry rewards and the potential impact of the eurozone crisis. Consequently, direct multinational operations are limited and domestic companies, such as Grindeks, have looked abroad for growth opportunities.

...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...

...

  
Source:
Document ID
1748-2003
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Latvia Pharmaceuticals and Healthcare Report" Aug 20, 2016. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Latvia-Pharmaceuticals-and-Healthcare-Report-2026-293>
  
APA:
Business Monitor International - Industry Reports. (2016). Latvia Pharmaceuticals and Healthcare Report Aug 20, 2016. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Latvia-Pharmaceuticals-and-Healthcare-Report-2026-293>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.